Passive Immunization with a Multicomponent Vaccine Against Conserved Domains of Apical Membrane Antigen 1 and 235-kilodalton Rhoptry Proteins Protects Mice Against Plasmodium Yoelii Blood-stage Challenge Infection.
From: Malaria Vaccine Development Branch/NIH, 5640 Fishers Lane, Twinbrook I, Rockville, MD 20852, USA. dnarum@niaid.nih.gov
Infection and immunity
- Publish Date: Oct 2006
- ISSN: 0019-9567
- Volume: 74
- Issue: 10
- Pages: 5529-36
- Medium: Print
- Language: English
- Citation (JAMA): Narum David L, Ogun Solabomi A, Batchelor Adrian H, et al. Passive Immunization with a Multicomponent Vaccine Against Conserved Domains of Apical Membrane Antigen 1 and 235-kilodalton Rhoptry Proteins Protects Mice Against Plasmodium Yoelii Blood-stage Challenge Infection.. Infect. Immun. Oct 2006;74:5529-36
Abstract
During malaria parasite invasion of red blood cells, merozoite proteins bind receptors on the surface of the erythrocyte. Two candidate Plasmodium yoelii adhesion proteins are apical membrane antigen 1 (AMA1) and the 235-kDa rhoptry proteins (P235). Previously, we have demonstrated that passive immunization with monoclonal antibodies (MAbs) 45B1 and 25.77 against AMA1 and P235, respectively, protects against a lethal challenge infection with P. yoelii YM. We show that MAb 45B1 recognizes an epitope located on a conserved surface of PyAMA1, as determined by phage display and analysis of the three-dimensional structure of AMA1, in a region similar to that bound by the P. falciparum AMA1-specific inhibitory antibody 4G2. The epitope recognized by 25.77 could not be assigned. We report here that MAbs 45B1 and 25.77 also protect against challenge with the nonlethal parasite line 17X, in which PyAMA1 has a significantly different amino acid sequence from that in YM. When administered together, the two MAbs acted at least additively in providing protection against challenge with the virulent YM parasite. These results support the concept of developing a multicomponent blood-stage vaccine and the inclusion of polymorphic targets such as AMA1, which these results suggest contain conserved domains recognized by inhibitory antibodies.
Mesh Headings (Keywords): Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Protozoan, Blood, Epitopes, Immunization, Passive, Malaria, Malaria Vaccines, Membrane Proteins, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Plasmodium yoelii, Protein Structure, Tertiary, Protozoan Proteins
Check for Full Text / PubMed Unique Identifier (PMID): 16988228
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.